The role of the complement system in the pathomechanism of obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Is there a relationship between OSAS severity and Nesfatin-1? Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Potential role of inflammatroy factors in Sleep Apnea Hypopnea Syndrome associated pulmonary hypertension Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018
The role of hypoxia and the circadian rhythm in sleep apnoea Source: International Congress 2015 – A bout de souffle: hypoxia and sleep-disordered breathing Year: 2015
Protective cardiovascular effect of sleep apnea severity in obesity hypoventilation syndrome Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Obstructive sleep apnea is associated with alterations in markers of feto-placental wellbeing Source: Annual Congress 2013 –A paediatric palimpsest: sleep apnoea from conception to the teenage years Year: 2013
The impact of CPAP on circulating IGF-1 in patients with OSAS Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation Year: 2016
Increased circulating fibrocytes in asthmatic patients with severe OSA Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016
Assessment of impaired in vitro endothelial repair function in obstructive sleep apnea patients and impact of associated metabolic syndrome Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing Year: 2013
How does obstructive sleep apnea syndrome effect renal functions? Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities Year: 2016
Prevalence of clinical symptoms of sleep apnea hyponea syndrome during pregnancy Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies Year: 2015
Determinants of subclinical atherosclerosis in patients with obstructive sleep apnoea Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies Year: 2015
Progression of subclinical atherosclerosis in obstructive sleep apnoea (OSA) Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
OSA complication score as novel reference to assess systemic inflammation in sleep apnoea Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine Year: 2015
Cumulative association of OSA severity and sleep dept with hypertension Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions Year: 2014
Nocturia is an independent predictive factor of prevalent hypertension in obstructive sleep apnea patients Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters Year: 2014
Impact of septoplasty in the severity and treatment of sleep apnea Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing? Year: 2013
Relationship between obstructive sleep apnea syndrome, plasma homocysteine levels and cardiovascular risk Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Obesity and chronic intermittent hypoxia are independent risk factors for clinical decompensation in patients with cirrhosis and OSAS Source: International Congress 2014 – Inflammation and obesity: implications for OSA Year: 2014